Journal of the Neurological Sciences
Volume 205, Issue 1 , Pages 77-81 , 15 December 2002

Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis

  • Neeraj Dubey

      Affiliations

    • Dent Neurologic Institute, Buffalo, NY, USA
    • Imaging Services, Kaleida Health-Millard Fillmore Hospital, Buffalo, NY, USA
    • ,
  • Robert S Miletich

      Affiliations

    • Dent Neurologic Institute, Buffalo, NY, USA
    • Imaging Services, Kaleida Health-Millard Fillmore Hospital, Buffalo, NY, USA
    • Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
    • ,
  • Mohammad Wasay

      Affiliations

    • Department of Neurology, The Aga Khan University, Karachi, Pakistan
    • ,
  • Laszlo L Mechtler

      Affiliations

    • Dent Neurologic Institute, Buffalo, NY, USA
    • Imaging Services, Kaleida Health-Millard Fillmore Hospital, Buffalo, NY, USA
    • Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
    • ,
  • Rohit Bakshi

      Affiliations

    • Corresponding Author InformationCorresponding author. Buffalo Neuroimaging Analysis Center, The Jacobs Neurological Institute, 100 High St. Buffalo, NY 14203, USA. Tel.: +1-716-859-7592; fax: +1-716-859-7573.
    • Dent Neurologic Institute, Buffalo, NY, USA
    • Imaging Services, Kaleida Health-Millard Fillmore Hospital, Buffalo, NY, USA
    • Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA
    • Buffalo Neuroimaging Analysis Center, The Jacobs Neurological Institute, Buffalo, NY, USA

Received 22 October 1999 ,Revised 28 June 2002 ,Accepted 3 July 2002.

References 

  1. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology. 1993;43:8–12
  2. Oksanen V. Neurosarcoidosis. Sarcoidosis. 1994;11:76–79
  3. Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?. J. Nucl. Med. 1994;35:1650–1652
  4. Valind SO, Rhodes CG, Paltin C, Suzuki T, Hughes JMB. Measurement of pulmonary glucose metabolism in patients with cryptogenic fibrosing alveolitis and pulmonary sarcoidosis. Am. Rev. Resp. Dis. 1984;129:A53
  5. Lewis PJ, Salama A. Uptake of flourine-18-Flurodeoxuglucose in sarcoidosis. J. Nucl. Med. 1994;35:1647–1649
  6. Yamada Y, Uchida Y, Tatsumi K, et al.  Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J. Nucl. Med. 1998;39:1160–1166
  7. Brudin LH, Valind S-O, Rhodes CG, et al.  Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur. J. Nucl. Med. 1994;21:297–305
  8. Muggia FM, Conti PS. Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?. Ann. Oncol. 1998;9:924
  9. Kiatboonsri C, Resnick SC, Chan KM, et al.  The detection of recurrent sarcoidosis by FDG-PET in a lung transplant recipient. West. J. Med. 1998;168:130–132
  10. Miller DH, Kendall BE, Barter S, et al.  Magnetic resonance imaging in central nervous system sarcoidosis. Neurology. 1988;38:378–383
  11. Pascuzzi RM, Shapiro SA, Rau AN, et al.  Sarcoid myelopathy. J. Neuroimaging. 1996;6:61–62
  12. Bakshi R, Fenstermaker RA, Bates VE, et al.  Neurosarcoidosis presenting as a large suprasellar mass: magnetic resonance imaging findings. Clin. Imaging. 1998;22:323–326
  13. Bekerman C, Szidon JP, Pinsky S. The role of gallium-67 in the clinical evaluation of sarcoidosis. Semin. Roentgenol. 1985;20:400–409
  14. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, et al.  Glucose utilization of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography. Neurology. 1982;32:1323–1329
  15. Griffeth LK, Rich KM, Dehdashti F, Simpson JR, Fusselman MJ, McGuire AH, et al.  Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology. 1993;186:37–44
  16. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J. Nucl. Med. 1992;33:532–536
  17. Bakshi R, Miletich RS, Kinkel PR, et al.  High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J. Neuroimaging. 1998;8:228–234
  18. Sokoloff L. Circulation and energy metabolism of the brain. In:  Siegel GJ,  Agranoff BW,  Albers RW,  Molinoff PB editor. Basic neurochemistry: molecular, cellular, and medical aspects. 4th ed.. New York: Raven Press; 1989;p. 565–590
  19. Di Chiro G, Oldfield E, Bairamian D, et al.  Metabolic imaging of the brain stem and spinal cord: studies with positron emission tomography using 18F-2-deoxyglucose in normal and pathological cases. J. Comput. Assist. Tomogr. 1983;7:937–945
  20. Kamoto Y, Sadato N, Yonekura Y, et al.  Visualization of the cervical spinal cord with FDG and high-resolution PET. J. Comput. Assist. Tomogr. 1998;22:487–491
  21. Bakshi R, Mazziotta JC. Acute transverse myelitis after influenza vaccination: magnetic resonance imaging findings. J. Neuroimaging. 1996;6:248–250
  22. Bakshi R, Kinkel PR, Mechtler LL, et al.  Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis. Eur. J. Neurol. 1998;5:35–48
  23. Bhojo AK, Akhter N, Bakshi R, Wasay M. Thoracic myelopathy complicating acute meningococcal meningitis: MRI findings. Am. J. Med. Sci. 2002;323:263–265

PII: S0022-510X(02)00225-3

Journal of the Neurological Sciences
Volume 205, Issue 1 , Pages 77-81 , 15 December 2002

Article Tools

* Image Usage & Resolution